C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $169,958 | -26.6% | 91,380 | +8.5% | 0.00% | – |
Q2 2023 | $231,639 | +16.9% | 84,234 | +33.5% | 0.00% | – |
Q1 2023 | $198,134 | -46.3% | 63,102 | +0.9% | 0.00% | – |
Q4 2022 | $369,086 | -33.6% | 62,557 | -1.4% | 0.00% | -100.0% |
Q3 2022 | $556,000 | +153.9% | 63,432 | +118.4% | 0.00% | – |
Q2 2022 | $219,000 | – | 29,042 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |